As of 2026-03-22, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -109.9%.
The range of the Relative Valuation is (12.59) - (13.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 20.0x | 19.0x |
| Forward P/E multiples | 16.6x - 19.5x | 18.2x |
| Fair Price | (12.59) - (13.67) | (13.04) |
| Upside | -109.5% - -110.4% | -109.9% |
| Date | P/E |